Literature DB >> 35316374

Hypoxia preconditioning elicit differential response in tissue-specific MSCs via immunomodulation and exosomal secretion.

Suchi Gupta1, Sonali Rawat1, Vishnu Krishnakumar1, E Pranshu Rao1, Sujata Mohanty2.   

Abstract

Mesenchymal stromal cells (MSCs) are emerging as an ideal candidate for regenerative medicine. It is known that the culture conditions impact the cellular properties of MSCs and their therapeutic behavior. Moreover, maintenance of MSCs in low oxygen tension for a short duration has shown to be beneficial for MSCs as it is similar to that of their physiological niche. However, the precise mechanism through which hypoxia pre-conditioning affects MSCs is not clear yet. Thus, in this study, we have investigated the effect of hypoxia exposure (1% O2) on tissue-specific MSCs over a period of time under serum-free culture conditions and evaluated the changes in expression of immuno-modulatory molecules and exosome biogenesis and secretion markers. It was observed that all MSCs responded differentially towards hypoxia exposure as indicated by the expression of HIF-1α. Moreover, this short-term exposure did not induce any changes in MSCs cellular morphology, proliferation rate, and surface marker profiling. In addition, we observed an enhancement in the expression of immunomodulatory factors (HLA-G, PGE-2, and IDO) after hypoxia exposure of 12 to 24 h in all tissue-specific MSCs. Interestingly, we have also observed the upregulation in exosome secretion that was further corelated to the upregulation of expression of exosome biogenesis and secretion markers (ALIX, TSG101, RAB27a, RAB27b). Though there was a differential response of MSCs where WJ-MSCs and BM-MSCs showed upregulation of these markers at 6-12 h of hypoxia pre-conditioning, while AD-MSCs showed similar changes beyond 24 h of hypoxia exposure.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adipose tissue; Bone marrow; Exosomes; Hypoxia; Immunomodulation; Mesenchymal stromal cells; Wharton’s jelly

Mesh:

Year:  2022        PMID: 35316374     DOI: 10.1007/s00441-022-03615-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

Review 1.  MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between.

Authors:  Markus Babst
Journal:  Curr Opin Cell Biol       Date:  2011-05-11       Impact factor: 8.382

2.  Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells.

Authors:  Marieke Roemeling-van Rhijn; Fane K F Mensah; Sander S Korevaar; Maarten J Leijs; Gerjo J V M van Osch; Jan N M Ijzermans; Michiel G H Betjes; Carla C Baan; Willem Weimar; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2013-07-18       Impact factor: 7.561

Review 3.  Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

Authors:  Arian Aryani; Bernd Denecke
Journal:  Mol Neurobiol       Date:  2014-12-15       Impact factor: 5.590

Review 4.  Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.

Authors:  Joana R Ferreira; Graciosa Q Teixeira; Susana G Santos; Mário A Barbosa; Graça Almeida-Porada; Raquel M Gonçalves
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

5.  Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.

Authors:  Silvia K Schmidt; Sebastian Ebel; Eric Keil; Claudia Woite; Joachim F Ernst; Anika E Benzin; Jan Rupp; Walter Däubener
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

Review 6.  Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response.

Authors:  Arman Saparov; Vyacheslav Ogay; Talgat Nurgozhin; Medet Jumabay; William C W Chen
Journal:  Stem Cells Int       Date:  2016-10-16       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.